It exerts its effect by binding to programmed cell death ligand 1 (PD-L1) on the surface of T cells—this interaction inhibits T cell activation and proliferation, and ultimately impairs T cells’ cytotoxic capacity against tumor cells [9]. The gene discussed is CD274; the disease is neoplasm.